Cholecystokinin-mediated Synaptic Function and the Treatment of Neuropsychiatric Disease
- 1 July 1985
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 448 (1), 553-561
- https://doi.org/10.1111/j.1749-6632.1985.tb29948.x
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- A method for studying synaptosomal release of neurotransmitter candidates, as evaluated by studies on cortical cholecystokinin octapeptide releasePeptides, 1982
- Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sitesActa Physiologica Scandinavica, 1981
- Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neuronsNeuroscience, 1981
- Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in ratsJournal of Neural Transmission, 1981
- The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassayBrain Research, 1981
- The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampusBrain Research, 1981
- Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in miceEuropean Journal of Pharmacology, 1981
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous systemBrain Research, 1979